biotech IPOs

Article Index

60 Biotech Companies to Go Public Before April 1

biotech companies

Biotechnology is tech's fastest-growing sector. In fact, there are more than 100 biotech companies set to go public in 2015.

Of those 100 IPOs, 60 are expected to launch before April 1. So you have to move fast to ride this $320 billion biotech wave.

Those IPOs are all but certain to keep the biotech bull market going through the year. Biotech stocks have soared 290% in the past five years. That's more than triple the S&P's 88%.

And biotech IPOs are not the only catalysts that will lift biotech shares across the board in 2015.

IPO Calendar 2014: AMBX Leads Healthcare-Heavy Week

IPO Calendar 2014 update: This year, 212 companies have already held IPOs, and the healthcare industry has seen more companies go public than any sector.

Through Monday, 51 healthcare companies have made initial public offerings, accounting for 24% of the total U.S. IPO market.

Healthcare stocks are once again at the forefront of the IPO calendar this week as five of this week's seven IPOs are healthcare companies.

Here's a look at each company hitting the market this week, and the story behind each deal...

2014 IPO Market: Why Biotech IPOs Are Soaring

The 2014 IPO market is booming as 61 companies have already filed for initial public offerings. Biotech companies like Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) and Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE) have led the way with first-day gains of 207% and 101%, respectively.

The success of biotech IPOs has led Money Morning's Defense & Tech Specialist Michael Robinson to call this "the biotech century."

Read More…

IPO Calendar 2014 Dominated by Biotech

best biotech investments 2014

IPO Calendar 2014: This year is forecast to be a record year for initial public offerings (IPOs).

Over the January to March period, some 250 to 300 new issues will launch, according to professional services firm EY - a number not seen since the start of the 2008 financial crisis.

And biotech companies are the hottest issues to date.

Since 2000, no two-week period saw more than six new biotech issues - until now.

See which biotech IPOs could be the best investments now...